<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        42-44-93
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1993
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        PREPIDIL 0.5MG GEL IN 3G SYRINGE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DINOPROSTONE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Vaginal use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        3
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Pre-filled syringe
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store in a refrigerator (2°c – 8°c)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        71.85
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="PFIZER" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            PFIZER
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            PFIZER
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        G02AD02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>PREPIDIL 0.5 mg endocervical gel contains the prostaglandin dinoprostone and is indicated for maturation of an unfavourable cervix in pregnant women with at term, or near term pregnancy in whom induction of labour is required for medical or obstetric reasons. Your doctor would have satisfied them self that there are no conditions making the induction unsafe. It will only be given to you in a hospital or clinic which has a specialised obstetric unit.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take PREPIDIL</strong><strong>:</strong></p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;if you are allergic to dinoprostone or any other prostaglandin or any of the other ingredients of this medicine (listed in section 6). Signs of an allergic reaction include wheezing, breathlessness, swelling of the hands, face, itchy rash or redness of the skin.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; Your doctor will not use Prepidil to start or strengthen your labour in certain circumstances if:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Multiparity (six or more previous term pregnancies);</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Engagement of the head has not taken place;</p><ul><li>you have had a Caesarean section or any major surgery to your womb.</li></ul><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p><ul><li>you have been told that your baby is too big for your pelvis, is lying awkwardly or may be physically stressed.</li></ul><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Severe foetal heart rate abnormalities;</p><p>&middot;&nbsp;&nbsp;&nbsp; Obstetric conditions where either maternal or foetal risk/benefit ratio favours a surgical intervention;</p><ul><li>you have an infection of your womb, ovaries or tubes (pelvic inflammatory disease) unless you are receiving treatment for these, or if you have ever had such an infection in the past.</li><li>you have had unexplained bleeding from the vagina or spotting at any time during your pregnancy.</li></ul><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Baby not in head-down presentation,</p><ul><li>you had a difficult labour or traumatic delivery in a previous pregnancy.</li></ul><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Inferior part of foetus presenting above pelvic;</p><p>you have current heart, lung, kidney or liver disease</p><p><strong>Warnings and precautions </strong></p><p>&nbsp;</p><p>Talk to your doctor before they use this medicine if you have or have had in the past any of the following conditions as they may want to monitor you more closely:</p><ul><li>heart, lung, kidney or liver disease</li><li>glaucoma (raised pressure in the eye)</li><li>suffered from asthma</li><li>hypertension (high blood pressure) at any time, including during this or any previous pregnancy</li><li>been told you had abnormally strong contractions of your womb during a previous labour</li><li>scarring of your womb from a previous operation</li><li>you are 35 years or older</li><li>your pregnancy is over 40 weeks</li><li>Having complications related to this pregnancy</li><li>an increased risk of developing a generalised bleeding disorder, a condition known as post-partum disseminated coagulation</li><li>if you are having more than one baby</li><li>if your water has broken.</li></ul><p>&nbsp;</p><p>Your doctor will ask you questions before giving you PREPIDIL 0.5 mg endocervical gel to make sure it is safe for you.</p><p>&nbsp;</p><p>If you do not understand any of the questions, ask your doctor to explain.</p><p>&nbsp;</p><p><strong>Paediatric population</strong></p><p>The safety and efficacy of Prepidil in paediatric patients has not been established.&nbsp; There is no relevant use of Prepidil in paediatric patients other than adolescents.</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>Other medicines and &nbsp;PREPIDIL</strong></p><p>&nbsp;</p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>&nbsp;</p><p>PREPIDIL 0.5 mg endocervical gel can make you more sensitive to another medicine called oxytocin which is used to strengthen contractions. Medical staff will normally try not to use this medicine at the same time as PREPIDIL 0.5 mg endocervical gel. If you need this medicine, your doctor will make sure they are not given to you close together and will watch over the contractions very carefully.</p><p>&nbsp;</p><p><strong>PREPIDIL</strong><strong> with food and, drink and alcohol</strong></p><p><strong>&nbsp;</strong></p><p>Not applicable</p><p>&nbsp;</p><p><strong>Pregnancy and ,breast-feeding and fertility</strong></p><p>&nbsp;</p><p><strong>Pregnancy</strong></p><p>PREPIDIL will only be given to you in the late stages of pregnancy to induce labour.</p><p>. Any dose that produces sustained increased uterine tone could put the embryo or foetus at risk.</p><p>&nbsp;</p><p><strong>Breastfeeding</strong></p><p>prostaglandins are present in breast-milk they will not harm your baby and you may breast-feed as normal after delivery.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Fertility</strong></p><p>There are no clinical data on the effects of dinoprostone on fertility.</p><p>&nbsp;</p><p><strong>Driving and using machines</strong></p><p>&nbsp;</p><p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>PREPIDIL will be given to you by a trained professional in a hospital or clinic where facilities for monitoring you and your baby are available. In order to administer the product correctly, the patient should be recumbent and the cervix should be visualised by means of a speculum.</p><p>Insert the syringe gently into the endocervix (just below the internal cervical ostium) and with the catheter supplied, inject the full contents of the syringe (0.5 mg dinoprostone = 3 g PREPIDIL) gently, removing the catheter afterwards.</p><p>PREPIDIL should not be administered above the level of the internal cervical ostium.</p><p>After application of the gel the patient should remain recumbent for at least 15 minutes to ensure minimal leakage of the gel.</p><p>The contents of a syringe should be used for one patient only. It is not appropriate to attempt to administer the small amount of gel left in the catheter. The syringe, the catheter and any unused parts of the package contents should be discarded after use.</p><p>&nbsp;</p><p><u>Method of administration</u></p><p>Remove the sterile catheter and the sterile syringe from the package.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_s1026" type="#_x0000_t75" style='width:296.2pt;
 height:134.25pt;mso-position-horizontal-relative:char;
 mso-position-vertical-relative:line'>
 <v:imagedata src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image001.gif"
  o:title=""/>
 <w:wrap type="none"/>
 <w:anchorlock/>
</v:shape><![endif]--><img width="395" height="179" src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image001.gif" /></p><p>&nbsp;</p><p>1. Remove the protective cap (to be used as an extension of the plunger).</p><p>2. Place the protective cap in the syringe.</p><p>3. Fix the catheter firmly on the syringe (the catheter should click) and administer the contents.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>If you take more PREPIDIL</strong><strong> &nbsp;than you should</strong></p><p><strong>&nbsp;</strong></p><p>Since PREPIDIL 0.5 mg endocervical gel is only available in single dose syringe, symptoms of overdose can normally only occur depending on the individual patient sensitivity to the product. Since the clinical studies with prostagladin-antagonists have not yet progressed to the point where recommendations can be made, treatment of overdosage must, at this time, be symptomatic.</p><p>&nbsp;</p><p>Symptoms of overdosage may be uterine hypercontractility and uterine hypertonus that can result in foetal distress. Because of the transient nature of PGE2 -induced myometrial hyperstimulation, nonspecific, conservative management was found to be effective in the vast majority of the cases; i.e., maternal position change and administration of oxygen to the mother.</p><p>If uterine overstimulation (and/or foetal distress) is not resolved by discontinuation of the treatment, intravenous administration of a beta-2-mimetic can be useful. If tocolytic treatment does not produce results, immediate delivery is indicated.</p><p><strong>&nbsp;</strong></p><p>If you have any further questions on the use of this medicine, ask your doctor.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong>&nbsp;</strong></p><p><strong>Rare: may affect up to 1 in 1,000 people</strong></p><p>Rare but serious side effects which can sometimes happen include the following:</p><ul><li>tearing or bursting of the wall of your womb (uterine rupture)</li></ul><p><strong>If you get any of these symptoms please tell your doctor straight away.</strong></p><p>&nbsp;</p><p><strong>Common</strong><strong>: may affect up to 1 in 10 people</strong></p><ul><li>vomiting (being sick)</li><li>nausea (feeling sick)</li><li>backache</li><li>abnormally strong, frequent or long contractions of the womb</li><li>itching, soreness, rash or feeling of warmth of the vaginal area</li><li>slowing or quickening of the baby&rsquo;s heart rate and distress in the baby</li><li>running a high temperature</li></ul><p>&nbsp;</p><p>&nbsp;</p><p><strong>Not known: frequency cannot be estimated from the available data</strong></p><p>As prostaglandins make the body go into labour in the same way as it would happen naturally, anything that can happen in a natural labour can also happen if you have been given PREPIDIL. This includes:</p><ul><li>allergic/anaphylactic reactions, including anaphylactic shock (serious allergic reactions which can include skin rash, itching, wheezing, shortness of breath, swollen face, lips, hands, fingers, neck and throat, sudden drop in blood pressure, abdominal pain and collapse).</li><li>Rales, Shortness of breath; breathlessness, Chest discomfort, Cough</li></ul><ul><li>sudden blockage of a blood vessel with amniotic fluid (the fluid which surrounds the baby) or by a blood clot in the lungs. This could cause chest pain and shortness of breath.</li><li>placenta becoming detached</li><li>foetal death, stillbirth and death of the newborn baby (neonatal death); especially following serious events such as tearing of the womb</li><li>rash</li><li>baby born with an Apgar score lower than seven. (The Apgar score, which is measured on a scale of one to ten, is used to describe the baby&rsquo;s condition at birth. A low Apgar Score means that the baby&rsquo;s heart or lungs are not working properly.)</li><li>diarrhoea.</li></ul><ul><li>Leukocytosis</li></ul><ul><li>Pain</li></ul><p>&nbsp;</p><p>&nbsp;</p><p>Talk to your doctor about this if you want to know more, as they will be able to give you the information that you need.</p><p>&nbsp;</p><p>Studies have shown proliferation (thickening) of bone in new-born infants who have been treated with prostaglandins for a long time. There is no evidence that this occurs following short-term treatment with PREPIDIL.</p><p>A higher risk of a generalised bleeding disorder following delivery (post-partum disseminated intravascular coagulation-DIC) has been described in women who:</p><ul><li>are aged 35 and above.</li><li>whose pregnancies are more than 40 weeks.</li><li>who have pregnancy-related complications.</li></ul><p><strong>&nbsp;</strong></p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p>Reporting of side effects:<br />If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. By reporting side effects you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p><p><strong>To Report side effects</strong></p><p>&nbsp;</p><ul><li>Saudi Arabia</li></ul><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>National Pharmacovigilance Centre ( NPC )</p><ul><li>SFDA Call Center: 19999</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa</li></ul></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Store in a refrigerator (2&deg;‑ 8&deg;C).</p><p>&nbsp;</p><p>Keep this medicine out of the sight and reach of children.</p><p>&nbsp;</p><p>Do not take this medicine after the expiry date which is stated on the label, carton. The expiry date refers to the last day of that month.</p><p>&nbsp;</p><p>Do not throw away any medicines via wastewater . Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The active substance is 0.5 mg dinoprostone in 3 g endocervical gel.</p><p>The other ingredient(s) are Silica colloidal anhydrous &ndash; glycerol triacetate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                1 prefilled syringe containing 3 g gel (= 2.5 ml gel) and a catheter.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder </strong></p><p>Pfizer SA, Boulevard de la Plaine 17, 1050 Brussels, Belgium.</p><p>&nbsp;</p><p><strong>Manufacturer:</strong></p><p>Pfizer Manufacturing&nbsp; Belgium NV, Rijksweg 12, 2870 Puurs, Belgium</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                August 2021
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>بريبيديل هلام ٠,٥ ملجم مخصص لباطن عنق الرحم يحتوي على البروستاجلاندين دينوبروستون وهو مخصص لتوسيع عنق الرحم عندما يكون في وضع غير مناسب للولادة لدى السيدات اللاتي أكملن فترة حملهن، أو شارفن على إكمالها، حيث يكون من اللازم تحفيز المخاض لأسباب طبية أو أسباب تتعلق بالولادة. سيتأكد طبيبكِ بنفسه من عدم وجود&nbsp; حالات تجعل تحفيز المخاض غير آمن. سيُعطى لكِ في مستشفى أو عيادة لديها وحدة ولادة متخصصة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>موانع استعمال بريبيديل:</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; إذا كنتِ تعانين من حساسية تجاه دينوبروستون أو أي بروستاجلاندين آخر أو أي من المكونات الأخرى لهذا الدواء (المدرجة في القسم ٦). تتضمن علامات تفاعل الحساسية الأزيز، أو صعوبة التنفس، أو تورم اليدين، أو الوجه، أو الطفح الجلدي المصحوب بحكة، أو احمرار الجلد.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp; لن يستخدم طبيبكِ بريبيديل لبدء المخاض أو تقويته لديكِ في ظروف معينة في حالة:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; تكرر الولادة (ست مرات حمل مكتمل سابق أو أكثر)؛</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; عدم دخول رأس الجنين إلى الحوض؛</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; الخضوع لولادة قيصرية أو أي جراحة كبرى في رحمكِ.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; أخبرت أن طفلكِ كبير جدًا بالنسبة للحوض أو وضعه غير ملائم أو قد يكون مرهقًا جسديًا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; وجود اضطرابات شديدة في معدل ضربات قلب الجنين؛</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; حالات الولادة التي يكون فيها معدل الخطر مقارنة بالفائدة، سواء للأم أو الجنين، يرجح التدخل الجراحي؛</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; الإصابة بعدوى في الرحم أو المبيضين أو الأنبوبين (مرض التهاب الحوض)، إلا إذا كنتِ تتلقين علاجًا لها، أو إذا كنتِ قد أُصبت بمثل هذه العدوى في الماضي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; حدوث نزيف لا يمكن تفسيره من المهبل أو بقع دم في أي وقت خلال الحمل.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp; ألا يكون الطفل في وضعية الرأس للأسفل،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; المعاناة من مخاض صعب أو ولادة عسيرة في حمل سابق.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; الجزء السفلي من الجنين موجود أعلى الحوض؛</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp; الإصابة بأمراض حالية في القلب، أو الرئة، أو الكلى، أو الكبد.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاحتياطات عند استعمال بريبيديل</strong></p><p dir="RTL">تحدثي إلى طبيبكِ قبل استخدام هذا الدواء إذا كنتِ تعانين حاليًا أو فيما سبق من أي من الحالات التالية لأنه قد يرغب في مراقبتكِ عن كثب:</p><ul><li dir="RTL">أمراض القلب، أو الرئة، أو الكلى، أو الكبد</li><li dir="RTL">الجلوكوما (ارتفاع الضغط داخل العين)</li><li dir="RTL">الربو</li><li dir="RTL">ضغط الدم المرتفع في أي وقت، بما في ذلك أثناء هذا الحمل أو أي حمل سابق</li><li dir="RTL">إخباركِ أنه كانت لديكِ انقباضات قوية بشكل غير طبيعي في رحمكِ أثناء مخاض سابق</li><li dir="RTL">وجود تندب في رحمكِ نتيجة عملية سابقة</li><li dir="RTL">بلوغكِ ٣٥ عامًا من العمر أو أكثر</li><li dir="RTL">تجاوز حملكِ ٤٠ أسبوعًا</li><li dir="RTL">حدوث مضاعفات متعلقة بهذا الحمل</li><li dir="RTL">زيادة خطر الإصابة باضطراب النزيف المعمم، وهي حالة تُعرف بالتخثر المنتشر بعد الولادة</li><li dir="RTL">ولادة أكثر من طفل واحد</li><li dir="RTL">نزول الماء لديكِ</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL">سيطرح عليكِ طبيبكِ أسئلة قبل إعطائك بريبيديل ٠,٥ ملجم هلام لباطن عنق الرحم للتأكد من أنه آمن بالنسبة لكِ.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا لم تفهمي أي سؤال من الأسئلة، فاطلبي من طبيبكِ أن يشرحها لكِ.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>فئة الأطفال</strong></p><p dir="RTL">لم يتم التحقق من سلامة وفعالية بريبيديل في المريضات الأطفال.&nbsp; لا يوجد استخدام مناسب لبريبيديل في المريضات الأطفال بخلاف المراهقات.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>التداخلات الدوائية مع أخذ هذا المستحضر مع أي أدوية أخرى أو أعشاب أو مكملات غذائية</strong></p><p dir="RTL">أخبري طبيبكِ أو الصيدلي إذا كنت تتناولين أو تناولتِ مؤخرًا أو من الممكن أن تتناولي أي أدوية أخرى.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يجعلكِ بريبيديل ٠,٥ ملجم هلام لباطن عنق الرحم أكثر حساسية تجاه دواء آخر يُسمى أوكسيتوسين وهو يُستخدم لتقوية الانقباضات. سيحاول الطاقم الطبي عادةً عدم استخدام هذا الدواء بالتزامن مع بريبيديل ٠,٥ ملجم هلام لباطن عنق الرحم. إذا كنتِ تحتاجين إلى هذا الدواء، فسيتأكد طبيبكِ من عدم إعطائكِ الدوائين على فترات قريبة وسيراقب الانقباضات بعناية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تناول بريبيديل مع الطعام والشراب</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">لا ينطبق</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية والخصوبة</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل</strong></p><p dir="RTL">ستُعطين<strong> </strong>بريبيديل فقط في المراحل المتأخرة من الحمل لتحفيز المخاض.</p><p dir="RTL">يُمكن لاستخدام أي جرعة تسبب التوتر المتزايد والمستمر لعضلات الرحم أن يشكل خطرًا على الجنين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الرضاعة</strong></p><p dir="RTL">البروستاجلاندينات موجودة في لبن الأم ولن تضر طفلكِ ويمكنكِ الرضاعة بشكل طبيعي بعد الولادة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الخصوبة</strong></p><p dir="RTL">لا توجد بيانات إكلينيكية حول تأثيرات دينوبروستون على الخصوبة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تأثير بريبيديل على القيادة واستخدام الآلات</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">لا ينطبق</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">سيعطيك بريبيديل متخصص مدرَّب في مستشفى أو عيادة تتوفر بها المرافق اللازمة لمراقبتكِ أنتِ وطفلكِ. من أجل استخدام المنتج بشكل صحيح، ينبغي أن تكون المريضة مستلقية على ظهرها، وتنبغي مشاهدة عنق الرحم باستخدام منظار.</p><p dir="RTL">أدخلي المحقنة بعناية في باطن عنق الرحم (قبل بلوغ فوهة عنق الرحم الداخلية مباشرة) واحقني محتويات المحقنة بالكامل (٠,٥ ملجم من دينوبروستون = ٣ جم بريبيديل) برفق وباستخدام القثطرة المرفقة، ثم انزعي القثطرة بعد الانتهاء من ذلك.</p><p dir="RTL">ينبغي عدم حقن بريبيديل في مستوى يتخطى مستوى فوهة عنق الرحم الداخلية.</p><p dir="RTL">يجب أن تظل المريضة مستلقية على ظهرها لفترة لا تقل عن ١٥ دقيقة بعد الاستخدام لضمان الحد من تسرُّب الهلام.</p><p dir="RTL">يجب أن تُستخدم محتويات المحقنة لمريضة واحدة فقط. ينبغي عدم محاولة إعادة استخدام ما تبقى من الهلام في القثطرة. ينبغي التخلص من المحقنة، والقثطرة، وأي أجزاء أخرى غير مستخدمة بعد الانتهاء من استخدام الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><u>طريقة الإعطاء</u></p><p dir="RTL">أخرجي القثطرة والمحقنة المعقمتين من العبوة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">١. انزعي الغطاء الواقي (يستخدم فيما بعد كامتداد للمكبس).</p><p dir="RTL">٢. ضعي الغطاء الواقي في المحقنة.</p><p dir="RTL">٣. ثبتي القثطرة بإحكام في المحقنة (ينبغي أن تصدر القثطرة صوت طقطقة يدل على تثبيتها في مكانها) واحقني المحتويات.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الجرعة الزائدة من بريبيديل</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">نظرًا لأن هلام بريبيديل ٠,٥ ملجم المخصص لباطن عنق الرحم متوفر فقط في محاقن بجرعات فردية، فإن أعراض الجرعة الزائدة يمكن أن تحدث عادة فقط في المريضات اللاتي لديهن حساسية من الدواء بشكل فردي. ونظرًا لأن الدراسات الإكلينيكية التي تُجرى على مناهضات البروستاجلاندين لم تتطور بعد إلى درجة تسمح بوضع توصيات تتعلق بذلك، فإن علاج الجرعة المفرطة في الوقت الحالي يجب أن يكون بعلاج الأعراض.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد تكون أعراض الجرعة المفرطة هي زيادة انقباض عضلات الرحم أو فرط توترها، الأمر الذي يمكن أن يؤدي إلى إصابة الجنين بضائقة تنفسية. ونظرًا للطبيعة المؤقتة لفرط تحفيز عضلات الرحم بسبب بروستاجلاندين E2، فقد وُجد أن التعامل الشامل والمتحفظ مع الحالة يكون فعالًا في الغالبية العظمى من الحالات، أي، تغيير وضع الأم وإعطائها الأكسجين.</p><p dir="RTL">إذا لم تنته حالة فرط استثارة الرحم (و/أو الضائقة التنفسية لدى الجنين) بإيقاف العلاج، فقد يُفيد استخدام أحد محاكيات بيتا-٢ عن طريق الحقن في الوريد. إذا لم يفلح العلاج بالأدوية التي توقف انقباضات الرحم، فلا بد من الولادة فورًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كانت لديكِ أسئلة أخرى بخصوص استعمال هذا الدواء، فاسألي طبيبكِ.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو الحال بالنسبة لجميع الأدوية، من الممكن أن يسبب هذا الدواء أعراضًا جانبية، إلا أنها لا تصيب الجميع.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>نادرة: قد تصيب ما يصل إلى مريضة واحدة من بين كل ١٠٠٠ مريضة</strong></p><p dir="RTL">أعراض جانبية نادرة ولكنها خطيرة قد تحدث في بعض الأحيان وهي تتضمن ما يلي:</p><ul><li dir="RTL">تمزق أو انثقاب جدار الرحم (تمزق الرحم)</li></ul><p dir="RTL"><strong>إذا أُصبتِ بأي من هذه الأعراض، يُرجى إخبار طبيبكِ على الفور.</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>شائعة: قد تصيب ما يصل إلى مريضة واحدة من بين كل ١٠ مريضات</strong></p><ul><li dir="RTL">القيء</li><li dir="RTL">الغثيان (الشعور بالرغبة في التقيؤ)</li><li dir="RTL">ألم الظهر</li><li dir="RTL">انقباضات قوية أو متكررة أو طويلة بشكل غير طبيعي في الرحم</li><li dir="RTL">الحكة، أو التقرح، أو الطفح الجلدي، أو الشعور بسخونة في منطقة المهبل</li><li dir="RTL">تباطؤ أو تسارع معدل ضربات قلب الطفل والضيق لدى الطفل</li><li dir="RTL">ارتفاع درجة الحرارة</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>غير معروف: لا يمكن تقدير معدل تكرار حدوثها من البيانات المتاحة</strong></p><p dir="RTL">نظرًا لأن البروستاجلاندينات تجعل الجسم في حالة المخاض بنفس الطريقة التي كان سيصبح بها في حالة المخاض بشكل طبيعي، أي شيء يحدث في المخاض الطبيعي يمكنه أيضًا أن يحدث إذا أعطيت بريبيديل. يتضمن ذلك ما يلي:</p><ul><li dir="RTL">تفاعلات الحساسية/التفاعلات التأقية، بما في ذلك الصدمة التأقية (تفاعلات الحساسية الخطيرة التي يمكن أن تتضمن الطفح الجلدي، والحكة، والأزيز، وضيق التنفس، وتورم الوجه، والشفتين، واليدين، الأصابع، والعنق، والحلق، وانخفاض مفاجئ في ضغط الدم، وألم البطن، والهبوط).</li><li dir="RTL">صوت خرخرة في الصدر، ضيق التنفس؛ صعوبة التنفس، الشعور بالانزعاج في الصدر، السعال</li><li dir="RTL">انسداد مفاجئ في وعاء دموي بالسائل السلوي (السائل الذي يحيط بالطفل) أو بسبب جلطة دموية في الرئتين. وقد يتسبب هذا في ألم الصدر وضيق التنفس.</li><li dir="RTL">حدوث انفصال في المشيمة</li><li dir="RTL">وفاة الجنين وولادة الجنين ميت ووفاة الطفل المولود حديثًا (وفاة حديثي الولادة)؛ وخصوصًا بعد أحداث خطيرة مثل تمزق الرحم</li><li dir="RTL">الطفح الجلدي</li><li dir="RTL">ولادة الطفل بدرجة أقل من سبعة وفقًا لمقياس أبجار. (تُستخدم درجة مقياس أبجار، التي تُقاس على مقياس من واحد إلى عشرة، لوصف حالة الطفل عند الولادة. تعني الدرجة المنخفضة وفقًا لمقياس أبجار عدم عمل قلب الطفل أو رئتيه بشكل سليم.)</li><li dir="RTL">الإسهال</li><li dir="RTL">كثرة الكريات البيضاء</li><li dir="RTL">الألم</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL">تحدثي إلى طبيبكِ عن هذا إذا كنتِ ترغبين في معرفة المزيد، لأنه سيتمكن من إعطائكِ المعلومات التي تحتاجين إليها.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أظهرت الدراسات فرط نمو (تغلظ) العظام في الأطفال المولودين حديثًا الذين تعالجوا بالبروستاجلاندينات لفترة طويلة. ليس هناك دليل على حدوث هذا بعد العلاج قصير الأمد باستخدام بريبيديل.</p><p dir="RTL">وصفت زيادة خطر الإصابة باضطراب النزيف المعمم بعد الولادة (التخثر المنتشر داخل الأوعية الدموية بعد الولادة (DIC)) في النساء اللواتي:</p><ul><li dir="RTL">يبلغن من العمر ٣٥ عامًا فأكثر.</li><li dir="RTL">تجاوز حملهن ٤٠ أسبوعًا.</li><li dir="RTL">لديهن مضاعفات متعلقة بالحمل.</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">الإبلاغ عن الآثار الجانبية:<br />إذا أصبتِ بأي آثار جانبية، فتحدثي إلى طبيبك أو الصيدلي بشأنها. يشمل هذا أي آثار جانبية محتملة غير مدرجة في هذه النشرة. بالإبلاغ عن الآثار الجانبية، يمكنك المساعدة في توفير المزيد من المعلومات حول سلامة هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الإبلاغ عن الأعراض الجانبية</strong></p><p dir="RTL">&nbsp;</p><ul><li dir="RTL">المملكة العربية السعودية:</li></ul><p dir="RTL">&nbsp;</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المركز الوطني للتيقظ الدوائي:</p><ul><li dir="RTL">مركز الاتصال الموحد: ١٩٩٩٩</li><li dir="RTL">البريد الإلكتروني: npc.drug@sfda.gov.sa</li><li dir="RTL">الموقع الإلكتروني: https://ade.sfda.gov.sa</li></ul></td></tr></tbody></table><p dir="RTL">&nbsp;</p><ul><li dir="RTL">دول الخليج الأخرى:</li></ul><p dir="RTL">&nbsp;</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الرجاء الاتصال بالمؤسسات والهيئات الوطنية في كل دولة.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يُخزن في المبرد (٢ ‑ ٨ درجات مئوية).</p><p dir="RTL">&nbsp;</p><p dir="RTL">احتفظي بهذا الدواء بعيدًا عن مرأى ومتناول الأطفال.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تتناولي هذا الدواء بعد مرور تاريخ انتهاء الصلاحية المُبين على الملصق الموجود على العبوة. يشير تاريخ انتهاء الصلاحية إلى آخر يوم في ذلك الشهر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تتخلصي من أي أدوية عبر مياه الصرف. اسألي الصيدلي عن كيفية التخلص من الأدوية التي لم تعودي تستخدمينها. ستساعد هذه الإجراءات في حماية البيئة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>المادة الفعالة هي ٠,٥ ملجم من دينوبروستون في ٣ جم من الهلام المخصص لباطن عنق الرحم.</p><p dir="RTL">المكونات الأخرى هي سيليكا غروية لا مائية - ثلاثي أسيتات جليسرول.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>تحتوي كل محقنة مسبقة التعبئة على ٣ جم هلام (= ٢,٥ مل هلام) وقثطرة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>مالك تصريح التسويق </strong></p><p>Pfizer SA, Boulevard de la Plaine 17, 1050 Brussels, Belgium، بلجيكا.</p><p>&nbsp;</p><p><strong>الجهة المصنعة:</strong></p><p>Pfizer Manufacturing Belgium NV, Rijksweg 12, 2870 Puurs, Belgium، بلجيكا</p><p><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            أغسطس/آب ٢٠٢١
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                PREPIDIL 0.5 mg endocervical gel
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                PREPIDIL contains 0.5 mg dinoprostone in 3 g endocervical gel.
For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Endocervical gel.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>PREPIDIL 0.5 mg endocervical gel is indicated for maturation of an unfavourable cervix in pregnant women with at term, or near term pregnancy in whom induction of labour is required for medical or obstetric reasons.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Usage is restricted to qualified health care professionals and to hospitals and clinics with specialised obstetric units with facilities for continuous monitoring.</p><p>&nbsp;</p><p>The recommended dose should not be exceeded, and the dosing interval should not be shortened as this increases the risk of uterine hyperstimulation, uterine rupture, uterine haemorrhage, foetal and neonatal death.</p><p>&nbsp;</p><p><u>Posology</u></p><p>In order to administer the product correctly, the patient should be recumbent and the cervix should be visualised by means of a speculum.</p><p>Insert the syringe gently into the endocervix (just below the internal cervical ostium) and with the catheter supplied, inject the full contents of the syringe (0.5 mg dinoprostone = 3 g PREPIDIL) gently, removing the catheter afterwards.</p><p>PREPIDIL should not be administered above the level of the internal cervical ostium.</p><p>After application of the gel the patient should remain recumbent for at least 15 minutes to ensure minimal leakage of the gel.</p><p>The contents of a syringe should be used for one patient only. It is not appropriate to attempt to administer the small amount of gel left in the catheter. The syringe, the catheter and any unused parts of the package contents should be discarded after use.</p><p>&nbsp;</p><p><u>Method of administration</u></p><p>Remove the sterile catheter and the sterile syringe from the package.</p><p>&nbsp;</p><p>&nbsp;</p><p><!--[if gte vml 1]><v:shapetype id="_x0000_t75"
 coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe"
 filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="Picture_x0020_1" o:spid="_x0000_i1025" type="#_x0000_t75"
 style='width:295.8pt;height:133.8pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image001.png"
  o:title=""/>
</v:shape><![endif]--><img width="394" height="178" src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image002.jpg" /></p><p>&nbsp;</p><p>1. Remove the protective cap (to be used as an extension of the plunger).</p><p>2. Place the protective cap in the syringe.</p><p>3. Fix the catheter firmly on the syringe (the catheter should click) and administer the contents.</p><p>&nbsp;</p><p><em>Paediatric population</em></p><p>The safety and efficacy of Prepidil in paediatric patients has not been established.&nbsp; There is no relevant use of Prepidil in paediatric patients other than adolescents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Administration of PREPIDIL is contraindicated:
1.	In patients with a hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
2.	In patients in whom oxytocic drugs are generally contra-indicated, in case of :
•	Multiparity (six or more previous term pregnancies);
•	Engagement of the head has not taken place;
•	Previous uterine surgery (after caesarean section, hysterotomy etc.);
•	Cephalopelvic disproportion;
•	Foetal heart rate pattern suggests incipient foetal compromise;
•	Obstetric conditions where either maternal or foetal risk/benefit ratio favours a surgical intervention;
•	Unexplained vaginal discharge and/or abnormal uterine bleeding during current pregnancy;
•	Nonvertex presentation;
•	Infection of the lower genital tract;
•	History of difficult and/or traumatic delivery;
•	Inferior part of foetus presenting above pelvic;
•	Active cardiac, pulmonary, renal or hepatic disease;

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; This product should be used exclusively in hospitals and administered under medical surveillance.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; As with any oxytocic agent, the risk of uterine rupture should be considered. Concomitant medication, maternal and foetal status should be taken into consideration in order to minimise the risk of uterine hyperstimulation, uterine rupture, uterine haemorrhage, foetal and neonatal death. Continuous electronic monitoring of uterine activity and foetal heart rate should be conducted during use of dinoprostone. Patients who develop uterine hypertonus or hypercontractility, or in whom unusual foetal heart rate patterns develop, should be managed in a manner that addresses the welfare of the foetus and mother.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dinoprostone should be used with caution in patients with impaired cardiovascular, hepatic or renal function, asthma, glaucoma or raised intraocular pressure or ruptured chorioamniotic membranes. Dinoprostone should be used with caution in patients with multiple pregnancy.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Women aged 35 years or older, those with complications during pregnancy and those with a gestational age over 40 weeks have been shown to have an increased risk of post-partum disseminated intravascular coagulation. In addition, these factors may further increase the risk associated with labour induction (see section 4.8). Therefore, in these women, use of dinoprostone should be undertaken with caution. Measures should be applied to detect as soon as possible an evolving fibrinolysis in the immediate post-partum phase.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The feto-pelvic proportions should be carefully assessed before using PREPIDIL.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Animal studies in which high doses were administered for several weeks have revealed that prostaglandins belonging to the E and F series can cause bone proliferation. A similar effect has also been observed in new-born babies who received long-term treatment with prostaglandin E1. With short-term PREPIDIL treatment no such effects on bone have been demonstrated.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; PREPIDIL should not be applied above the level of the internal ostium of the cervix since uterine hyperstimulation has been observed with extra-amniotic administration.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The induction of labour in general is associated with the risk of amniotic fluid embolism (AFE) (also called Anaphylactoid syndrome of pregnancy).&nbsp; Cases of AFE have been reported after the use of different formulations of dinoprostone for cervical maturation (see section 4.8). The onset is often abrupt during labour and delivery/caesarean section or up till 48 hours post-partum.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The clinician should be alert that the intracervical placement of dinoprostone may result in inadvertent disruption and subsequent embolization of antigenic tissue causing in rare circumstances the development of amniotic fluid embolism (also known as anaphylactoid syndrome of pregnancy.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; As with all intra-uterine administrations it is necessary to consider the risk of local infections by extra-amniotic administration. In such cases, these infections should be treated.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe cardiovascular accidents, potentially fatal (myocardial infarction and/or ventricular fibrillation) have been reported with prostaglandins and prostaglandin analogues for injection. To date these accidents have never been reported following endocervical administration of PGE2. The risk of such accidents increases with age, chronic smoking and recent smoking. As a precautionary measure, female patients should be asked not to smoke during the days prior to dinoprostone administration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The response to oxytocin may be accentuated in the presence of exogenous prostaglandin therapy. Concurrent use with other oxytocic agents is not recommended. A dosing interval of at least 6 hours is recommended in case of oxytocin use is considered necessary following dinoprostone administration.</p><p>Therefore, it is recommended to carefully monitor the patient if these drugs are used in sequence.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Fertility</strong></p><p>There are no clinical data on the effects of dinoprostone on fertility.</p><p>&nbsp;</p><p><strong>Pregnancy</strong></p><p>PREPIDIL is indicated for treatment of pregnant women before term or during delivery. Any dose that produces sustained increased uterine tone could put the embryo or foetus at risk (see sections 4.4 and 4.8).</p><p>Animal studies have shown reproductive toxicity (see section 5.3).</p><p>&nbsp;</p><p><strong>Breastfeeding</strong></p><p>Prostaglandins are excreted in breast milk at very low concentrations.</p><p>No measurable differences were observed in the milk of mothers delivering prematurely and at term.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not relevant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Safety profile</u></p><p>The most commonly reported adverse drug reactions in clinical trials for topical formulations of dinoprostone (occurring in &gt;10% of patients) are vomiting in the mother and abnormal foetal heart rate in the infant.&nbsp;</p><p>Other adverse events reported in up to 10% of patients are nausea, back pain, pyrexia, uterine hypertonus, contraction uterine, increased, abnormal uterine contractions, foetal distress syndrome and vulvovaginal burning sensation.</p><p>&nbsp;</p><p><u>Tabulated list of adverse reactions</u></p><p><u>&nbsp;</u></p><p>The following table of undesirable effects and frequencies is based on data from clinical trials.&nbsp; Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.</p><p>&nbsp;</p><p>The incidence and the severity of undesirable effects due to dinoprostone are dose-dependent and are determined to a certain extent by the mode of administration. The undesirable effects listed below have been observed during administration of PREPIDIL and are categorized by frequency as follows:</p><p>Very common: &ge;1/10</p><p>Common: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &ge;1/100 to &lt;1/10</p><p>Uncommon: &nbsp;&nbsp;&nbsp;&nbsp; &ge;1/1000 to &lt;1/100</p><p>Rare: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &ge;1/10,000 to &lt;1/1000</p><p>Very rare: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &lt;1/10,000</p><p>Not known: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cannot be estimated from the available data</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:680px"><thead><tr><td style="vertical-align:top"><p>System Organ Class</p></td><td style="vertical-align:top"><p>Very Common</p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Very Rare</p></td><td style="vertical-align:top"><p>Not known</p></td></tr></thead><tbody><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Disseminated intravascular coagulation*</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Leukocytosis</p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Anaphylactic shock, Anaphylactic reaction, Anaphylactoid reaction, Hypersensitivity</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Rales, Dyspnoea, Chest discomfort, Cough</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>Vomiting</p></td><td style="vertical-align:top"><p>Nausea</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Diarrhoea</p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal, and connective tissue disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Back pain</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Pregnancy, puerperium and perinatal conditions</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Uterine contractions abnormal, Uterine hypertonus, Contractions uterine increased, Foetal distress syndrome</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Anaphylactoid syndrome of pregnancy*, Uterine rupture, Foetal death<sup>&sect;</sup>, Stillbirth<sup>&sect;</sup>, Neonatal death<sup>&sect;</sup>, Premature baby, Foetal acidosis</p></td></tr><tr><td style="vertical-align:top"><p>Reproductive system and breast disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Vulvovaginal burning sensation</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Pyrexia</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Pain</p></td></tr><tr><td style="vertical-align:top"><p>Investigations</p></td><td style="vertical-align:top"><p>Foetal heart rate abnormal</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>APGAR score low</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p>* see section 4.4<strong> </strong></p><p><sup>&sect;</sup> Foetal death, stillbirth, and neonatal death have been reported after application of dinoprostone, especially following the occurrence of serious events such as uterine rupture (see sections 4.2, 4.3 and 4.4).</p><p><strong>&nbsp;</strong></p><p><u>Reporting of suspected adverse reactions</u></p><p>Reporting suspected adverse reactions after <u>marketing</u> authorization of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions <u>according to their local country requirements</u>.</p><p>&nbsp;</p><p><strong>To Report side effects</strong></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp; Saudi Arabia</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>National Pharmacovigilance Centre (NPC)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Since PREPIDIL 0.5 mg endocervical gel is only available in single dose syringe, symptoms of overdose can normally only occur depending on the individual patient sensitivity to the product. Since the clinical studies with prostagladin-antagonists have not yet progressed to the point where recommendations can be made, treatment of overdosage must, at this time, be symptomatic.</p><p>&nbsp;</p><p>Symptoms of overdosage may be uterine hypercontractility and uterine hypertonus that can result in foetal distress. Because of the transient nature of PGE2 -induced myometrial hyperstimulation, nonspecific, conservative management was found to be effective in the vast majority of the cases; i.e., maternal position change and administration of oxygen to the mother.</p><p>If uterine overstimulation (and/or foetal distress) is not resolved by discontinuation of the treatment, intravenous administration of a beta-2-mimetic can be useful. If tocolytic treatment does not produce results, immediate delivery is indicated.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: oxytocic drugs</p><p>ATC code: G02AD02</p><p>&nbsp;</p><p>Dinoprostone or prostaglandin E2 (PGE2) belongs to a family of natural unsaturated fatty acids.</p><p>Prostaglandins have very different pharmacological properties, including the ability to stimulate organs containing smooth muscle and to modulate the response of organs to other hormonal stimuli.</p><p>Endocervically administered dinoprostone facilitates maturation of the uterine cervix in patients with unfavourable induction features. The specific mechanism of action has not yet been fully established. However, it has been demonstrated experimentally that in humans the blood volume circulating in the cervix increases just as it does during the initial stages of spontaneous labour. These data clearly indicate that endocervical administration of dinoprostone stimulates the cervical haemodynamics and therefore induces maturation.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Natural prostaglandins are produced very rapidly out of corresponding free polyunsaturated fatty acids. Even minimal amounts of these substances produce significant changes, after which they are rapidly converted into non-active metabolites.</p><p>After endocervical administration of 0.5 mg dinoprostone (gel), peak plasma levels in the peripheral circulation were observed after 30 to 40 minutes. The levels rapidly return to baseline afterwards. This is independent of uterine contractions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Nonclinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity and genotoxicity.</p><p>&nbsp;</p><p>There was some evidence of a low level of teratogenic activity, with skeletal abnormalities observed in the rat when dams were dosed subcutaneously at 3.3 mg/kg/day.&nbsp; There was also evidence of embryotoxicity, likely mediated as a result of increased uterine tone.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Silica colloidal anhydrous &ndash; glycerol triacetate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Shelf life: 24 months


Do not use Prepidil after the expiry date which is stated on the Vial label after EXP:. The expiry date refers to the last day of that month

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store in a refrigerator (2&deg;‑ 8&deg;C).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>1 prefilled syringe containing 3 g gel (= 2.5 ml gel) and a catheter.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Keep out of the sight and reach of children.</p><p><strong>&nbsp;</strong></p><p>No special requirements.</p><p>&nbsp;</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p><p>&nbsp;</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                MARKETING AUTHORISATION HOLDER
Pfizer SA, Boulevard de la Plaine 17, 1050 Brussels, Belgium.

Manufacturer :
Pfizer Manufacturing  Belgium NV, Rijksweg 12, 2870 Puurs, Belgium

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                August 2021
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>